Next Generation News and Research

RSS

Analysis reveals overutilization of imaging in Bell's palsy

This study analyzes how imaging is used to diagnose and manage Bell's palsy, a condition that causes sudden weakness in the muscles on one side of the face, usually temporarily.

14 Nov 2025

Terasaki Institute and Caltech join forces on groundbreaking embryo formation study

The Terasaki Institute for Biomedical Innovation (TIBI) is pleased to announce its collaboration with the California Institute of Technology (Caltech) on a newly awarded $2.8 million Discovery Stage Research (DISC0) grant from the California Institute for Regenerative Medicine (CIRM).

14 Nov 2025

Enhancing the cancer-immunity cycle through innovative vaccines

Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in oncology toward harnessing the immune system's intrinsic ability to combat malignancies.

14 Nov 2025

Transforming colorectal cancer research with patient-derived xenograft models

Patient-derived xenograft (PDX) models are emerging as a transformative tool in colorectal cancer (CRC) research, offering unparalleled insights into tumor biology, drug resistance, and personalized treatment approaches.

14 Nov 2025

Bringing accessible NGS-based proteomics to even more labs

At Olink, our mission has always been clear: to make high-quality proteomics accessible to every lab.

From Olink®- Part of Thermo Fisher Scientific 13 Nov 2025

New study reveals how the uterus senses force to drive labor

When labor begins, the uterus must coordinate rhythmic, well-timed contractions to deliver the baby safely.

13 Nov 2025

New symposium empowers early career scientists in stem cell and developmental biology

For the first time, the International Society for Stem Cell Research (ISSCR), the Society for Developmental Biology (SDB), and the Allen Institute are collaborating to present a three-day scientific symposium led by early-career scientists.

13 Nov 2025

Lymphoma resistance mechanisms and future therapies

A new review was published in Volume 12 of Oncoscience on October 13, 2025, titled "Targeted therapies and resistance mechanisms in lymphoma: Current landscape and emerging solutions."

13 Nov 2025

Local anesthetic lidocaine may mitigate pancreatic cancer metastasis

Pinned between the stomach and spine, the pancreas supervises both digestion and blood sugar in the body. It's also the site of an aggressive cancer called pancreatic ductal adenocarcinoma, or PDAC.

13 Nov 2025

Collaborative effort advances next-generation therapies for pancreatic and GI cancers

Last year, researchers at the University of California, Riverside, developed a novel "molecular crowbar" strategy to degrade the oncogenic enzyme Pin1, a protein that is overexpressed in many tumors including pancreatic cancer.

12 Nov 2025

Study reveals challenges in accessing wheelchairs through Medicare-listed suppliers

Published today in Mayo Clinic Proceedings, a University of Minnesota Medical School research team found that access to wheelchairs through Medicare-listed suppliers is inconsistent and often challenging.

12 Nov 2025

Age and flu vaccine type influence immune activation

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune system that help to protect against infection varied greatly depending on the vaccine type and age of the patient.

12 Nov 2025

LabVantage Solutions awarded $22.3 million U.S. customs and border protection contract to deliver next-generation forensic LIMS

LabVantage Solutions, Inc., a global provider of laboratory informatics solutions and services, today announced it has been awarded a contract by the U.S. Department of Homeland Security's Customs and Border Protection (CBP) valued at up to $22.3 million over ten years. The agreement supports modernization of the agency's Forensic Laboratory Information Management System (FLIMS) to advance scientific and forensic operations that underpin U.S. border security and trade enforcement.

From LabVantage Solutions 12 Nov 2025

Breakthrough in bone regeneration using nanoparticle-stem cell hybrid

A research team in South Korea has successfully developed a novel technology that combines nanoparticles with stem cells to significantly improve 3D bone tissue regeneration.

12 Nov 2025

Prior exposure to cold viruses boosts antibody response against SARS-CoV-2

Prior exposure to coronaviruses that cause ordinary colds can boost the immune system's ability to attack a vulnerable site on the COVID-19-causing coronavirus SARS-CoV-2, according to a study led by investigators at Weill Cornell Medicine.

11 Nov 2025

Groundbreaking vaccination approach could transform respiratory disease prevention

A research team from Trinity College Dublin has unveiled a groundbreaking new approach to vaccination that could redefine how we protect against respiratory infections.

10 Nov 2025

Studies uncover two novel, critical strategies for bacterial surface movement

New studies from Arizona State University reveal surprising ways bacteria can move without their flagella - the slender, whip-like propellers that usually drive them forward.

8 Nov 2025

Rockefeller scientists engineer next-generation antibody to replace IVIG therapy

Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions.

7 Nov 2025

New initiative focuses on advancing human disease research through AI and frontier biology

Mark Zuckerberg and Priscilla Chan today announced the launch of a first-of-its-kind initiative combining frontier artificial intelligence and frontier biology to dramatically accelerate scientific progress toward understanding and addressing human disease.

7 Nov 2025

BIOVECTRA and Revolution Biomanufacturing partner to deliver integrated mRNA Design and GMP production services

BIOVECTRA, a part of Agilent Technologies Inc., and Revolution Biomanufacturing Inc. today announced a collaboration that grants BIOVECTRA access to Revolution Biomanufacturing's proprietary platforms for optimizing untranslated regions (UTRs) and codon usage to enhance mRNA stability and translational efficiency.

6 Nov 2025

Next Generation News and Research

Analysis reveals overutilization of imaging in Bell's palsy

Terasaki Institute and Caltech join forces on groundbreaking embryo formation study

Enhancing the cancer-immunity cycle through innovative vaccines

Transforming colorectal cancer research with patient-derived xenograft models

Bringing accessible NGS-based proteomics to even more labs

New study reveals how the uterus senses force to drive labor

New symposium empowers early career scientists in stem cell and developmental biology

Lymphoma resistance mechanisms and future therapies

Local anesthetic lidocaine may mitigate pancreatic cancer metastasis

Collaborative effort advances next-generation therapies for pancreatic and GI cancers

Study reveals challenges in accessing wheelchairs through Medicare-listed suppliers

Age and flu vaccine type influence immune activation

LabVantage Solutions awarded $22.3 million U.S. customs and border protection contract to deliver next-generation forensic LIMS

Breakthrough in bone regeneration using nanoparticle-stem cell hybrid

Prior exposure to cold viruses boosts antibody response against SARS-CoV-2

Groundbreaking vaccination approach could transform respiratory disease prevention

Studies uncover two novel, critical strategies for bacterial surface movement

Rockefeller scientists engineer next-generation antibody to replace IVIG therapy

New initiative focuses on advancing human disease research through AI and frontier biology

BIOVECTRA and Revolution Biomanufacturing partner to deliver integrated mRNA Design and GMP production services

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News